{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:48:14Z","timestamp":1764510494546},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12185-014-1576-0","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T05:13:23Z","timestamp":1398143603000},"page":"737-742","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma"],"prefix":"10.1007","volume":"99","author":[{"given":"Shogo","family":"Kumagai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Tashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Sueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soshi","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"1576_CR1","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification project. Blood 1997; 89:3909-18.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"1576_CR2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258\u201365.","journal-title":"Blood."},{"key":"1576_CR3","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2. J Clin Oncol. 2009;27:4555\u201362.","journal-title":"J Clin Oncol."},{"key":"1576_CR4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159\u201369.","journal-title":"N Engl J Med."},{"key":"1576_CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2011.050138","volume":"97","author":"LF Porrata","year":"2012","unstructured":"Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, et al. Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in classical Hodgkin\u2019s lymphoma. Haematologica. 2012;97:262\u20139.","journal-title":"Haematologica."},{"key":"1576_CR6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1634\/theoncologist.2012-0034","volume":"17","author":"YW Koh","year":"2012","unstructured":"Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, et al. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin\u2019s lymphoma: correlation with tumor-associated macrophages. Oncologist. 2012;17:871\u201380.","journal-title":"Oncologist."},{"key":"1576_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2141.2012.09067.x","volume":"157","author":"LF Porrata","year":"2012","unstructured":"Porrata LF, Ristow K, Habermann TM, Witzig TE, Colgan JP, Inwards DJ, et al. Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma. Br J Haematol. 2012;157:321\u201330.","journal-title":"Br J Haematol."},{"key":"1576_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. International harmonization project on lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579\u201386.","journal-title":"J Clin Oncol."},{"key":"1576_CR9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc."},{"key":"1576_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10428190903370338","volume":"51","author":"A Tzankov","year":"2010","unstructured":"Tzankov A, Zlobec I, Went P, Robl H, Hoeller S, Dirnhofer S. Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores. Leuk Lymphoma. 2010;51:199\u2013212.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1576_CR11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12185-010-0674-x","volume":"92","author":"P Solal-C\u00e9ligny","year":"2010","unstructured":"Solal-C\u00e9ligny P, Cahu X, Cartron G. Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful? Int J Hematol. 2010;92(2):246\u201354.","journal-title":"Int J Hematol."},{"key":"1576_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hon.2900120104","volume":"12","author":"D Parker","year":"1994","unstructured":"Parker D, Alison DL, Barnard DL, Child JA, Dovey G, Farish J, et al. Prognosis in low grade non-Hodgkin\u2019s lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level. Hematol Oncol. 1994;12:15\u201327.","journal-title":"Hematol Oncol."},{"key":"1576_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/annonc\/mdg015","volume":"14","author":"D Decaudin","year":"2003","unstructured":"Decaudin D, Des Guetz G, Mathiot C, Dumont J, Hubert P, Vincent-Salomon A, et al. Absolute lymphocyte count as a predictive factor for response to monoclonal anti-CD20 antibody therapy. Ann Oncol. 2003;14:171\u20132.","journal-title":"Ann Oncol."},{"key":"1576_CR14","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69:5383\u201391.","journal-title":"Cancer Res."},{"key":"1576_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2007.06596.x","volume":"137","author":"D Behl","year":"2007","unstructured":"Behl D, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, et al. Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas. Br J Haematol. 2007;137:409\u201315.","journal-title":"Br J Haematol."},{"key":"1576_CR16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.leukres.2013.07.038","volume":"37","author":"D Shafer","year":"2013","unstructured":"Shafer D, Smith MR, Borghaei H, Millenson MM, Li T, Litwin S, Anad R, Al-Saleem T. Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma. Leuk Res. 2013;37:1213\u20135.","journal-title":"Leuk Res."},{"key":"1576_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/10428194.2011.637211","volume":"53","author":"RA Wilcox","year":"2012","unstructured":"Wilcox RA, Ristow K, Habermann TM, Inwards DJ, Micallef IN, Johnston PB, et al. The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma. 2012;53:575\u201380.","journal-title":"Leuk Lymphoma."},{"key":"1576_CR18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2010-05-283820","volume":"117","author":"Y Lin","year":"2011","unstructured":"Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB. Immunosuppressive CD14\u00a0+\u00a0HLA-DR (low)\/-monocytes in B-cell non-Hodgkin lymphoma. Blood. 2011;117:872\u201381.","journal-title":"Blood."},{"key":"1576_CR19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.leukres.2013.07.015","volume":"37","author":"R Watanabe","year":"2013","unstructured":"Watanabe R, Tomita N, Kishimoto K, Koyama S, Ogusa E, Ishii Y, et al. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Res. 2013;37:1208\u201312.","journal-title":"Leuk Res."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1576-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1576-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1576-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T05:18:08Z","timestamp":1597727888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1576-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1576-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]}}}